2014

The Zacks Analyst Blog Highlights: Merck, Telefonica, BT Group, Vodafone Group and Liberty Global

CHICAGO, July 18, 2013 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Merck (NYSE: MRK-Free Report), Telefonica (NYSE: TEF-Free Report), BT Group Plc. (NYSE: BT-Free Report), Vodafone Group Plc. (Nasdaq: VOD-Free Report) and Liberty Global Plc. (Nasdaq: LBTYA-Free Report).

(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Wednesday's Analyst Blog:

Merck Candidate Faces Delay

Merck (NYSE: MRK-Free Report) suffered another pipeline-related setback recently with the US Food and Drug Administration (FDA) cancelling an advisory panel meeting for sugammadex. Merck is looking to get sugammadex approved for the reversal of neuromuscular blockade (NMB) induced by rocuronium or vecuronium.

Merck said that the FDA cancelled the Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) meeting which was scheduled to be held on Jul 18. The agency said that it needs more time to evaluate the results of a recently completed inspection of a clinical trial site. The site is one of four sites where a hypersensitivity study was conducted as per the FDA's requirements.

Merck is currently in discussions with the FDA regarding the path forward. The delay in sugammadex' approval is disappointing. We note that Merck had failed to gain US approval for sugammadex earlier in 2008. At that time, the FDA had asked for additional data related to hypersensitivity reactions and bleeding events.

Sugammadex, however, is marketed in 40 countries other than the US under the trade name Bridion. Bridion sales were $261 million in 2012, up 29.9%.

The delay in sugammadex's US approval is the second regulatory setback for Merck this month. Earlier this month, Merck had received a complete response letter (CRL) from the agency for its insomnia candidate, suvorexant.

Merck currently carries a Zacks Rank #4 (Sell).

O2, Virgin Media Ink Backhaul Deal

O2, the European subsidiary of Telefonica (NYSE: TEF-Free Report), has signed a long-term backhaul deal with U.K.-based cable provider, Virgin Media Business. The deal will allow O2 customers across the U.K. to enjoy faster network speed.

In a ten-year deal, Virgin Media Business will connect O2's base stations with its fibre network, via an Ethernet-based backhaul service. The high capacity Ethernet service will deliver 1Gbps data speed across cell sites and different parts of O2's network.

Recently, Telefonica paid nearly $830.6 million (£550 million) to secure 4G spectrums in the 800 MHz band and plans to launch 4G mobile service later this year. Other than Telefonica, Everything Everywhere (EE), Hutchison Whampoa,BT Group Plc. (NYSE: BT-Free Report) andVodafone Group Plc. (Nasdaq: VOD-Free Report) have also acquired 4G spectrum in the U.K.

Over the last couple of years, Virgin Media Business, a subsidiary of Liberty Global Plc. (Nasdaq: LBTYA-Free Report), has secured mobile backhaul deals from the four major mobile operators in the U.K. According to the company, the deal signifies the importance of backhaul network for supporting wireless services. Earlier this year, the company signed a $74 million (£49 million) deal with Sky U.K. to enhance its backhaul capacity.

In the last few years, there has been unprecedented adaptation of smartphones and tablets, which in turn has led to increased data demand. Higher proliferation of smartphones and tablets along with increased games and HD-movie downloads are pressurizing networks, resulting in slower network speed.

Last year, O2's rival, EE, launched nationwide 4G service based on its 1800 MHz band and is planning to increase its 4G speed to 150 MB per second. O2 believes that tying up with Virgin Media Business will boost its network speed and ease data congestion, satisfying customers.

With the expansion of 4G services, the demand for data is expected to rise. The partnership with Virgin Media Business will strengthen O2's position against EE. However, an indebted balance sheet of the parent company remains the primary concern for O2, which might force the company to delay the launch of its 4G service.

Currently, Telefonica carries a Zacks Rank #4 (Sell).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on MRK - FREE

Get the full Report on TEF - FREE

Get the full Report on BT - FREE

Get the full Report on VOD - FREE

Get the full Report on LBTYA - FREE

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

SOURCE Zacks Investment Research, Inc.



RELATED LINKS
http://www.zacks.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.